Loading...
Loading...
African Journal of Biology and Medical Research
Vol. 7Issue 32024pp. 1–8Published 12 July 2024
DOI 10.52589/AJBMR-ZHACEWRGShare Link
Cite this
Citation unavailable for this article.
Abstract:
This is a retrospective study covering the period 2022-2023 on urine samples received at the bacteriology-virology laboratory of the CHNU of FANN. The aim was to determine the prevalence and sensitivity profile of ESBL-producing strains of Klebsiella spp to other antibiotic molecules. A total of 549 urine samples were positive for a bacterium, of which 113 (20.58%) were attributable to Klebsiella spp., with a predominance of Klebsiella pneumoniae n=90 (79.65%). 59.26% were producers of extended-spectrum betalactamase (ESBL), of which 56.25% (n=27/48) were of hospital origin. Good sensitivity was noted to imipenem (78.40%) and amikacin (70.59%).
Disclaimer/Publisher’s Note
The statements, opinions and data contained in this publication are solely those of the author(s) and contributor(s) and not of AB Journals or its editors. AB Journals remains neutral and accepts no responsibility for any injury or damage resulting from ideas, methods, instructions or products referred to in the content.
Copyrights